Nature Biotechnology - Issue - nature.com science feeds - RSS Feed

Nature Biotechnology journal featuring biotechnology articles and science research papers of commercial interest in pharmaceutical, medical, and environmental sciences.

Latest articles

Identifying transcriptional programs underlying cancer drug response with TraCe-seq

Nature Biotechnology, Published online: 16 September 2021; doi:10.1038/s41587-021-01005-3Transcriptional mechanisms of drug response are identified with scRNA-seq and molecular barcoding.

Oncologists greet Lumakras: the world’s first KRAS inhibitor

Nature Biotechnology, Published online: 09 September 2021; doi:10.1038/s41587-021-01053-9The milestone approval for Amgen’s drug Lumakras will galvanize targeted therapy efforts against Ras oncoproteins and provides a powerful new last line of defense for patients with lung cancer.

Organoids

Nature Biotechnology, Published online: 09 September 2021; doi:10.1038/s41587-021-01055-7Recent patents relating to methods of making and using organoids.

First rounders: Anthony Atala

Nature Biotechnology, Published online: 09 September 2021; doi:10.1038/s41587-021-01064-6First rounders: Anthony Atala

Biotech news from around the world

Nature Biotechnology, Published online: 09 September 2021; doi:10.1038/s41587-021-01052-wBiotech news from around the world

First HIF-2 antagonist for VHL tumors

Nature Biotechnology, Published online: 09 September 2021; doi:10.1038/s41587-021-01063-7First HIF-2 antagonist for VHL tumors

First interchangeable insulin

Nature Biotechnology, Published online: 09 September 2021; doi:10.1038/s41587-021-01062-8First interchangeable insulin

CRISPR-based portable COVID tests

Nature Biotechnology, Published online: 09 September 2021; doi:10.1038/s41587-021-01061-9CRISPR-based portable COVID tests

People

Nature Biotechnology, Published online: 09 September 2021; doi:10.1038/s41587-021-01054-8Recent moves of note in and around the biotech and pharma industries.

Hope lies in dreams

Nature Biotechnology, Published online: 15 September 2021; doi:10.1038/d41587-021-00015-5Stan Crooke rose from poverty to found a company that pioneered antisense drugs. After decades of struggle and years of public doubt, the company created a treatment that has saved thousands of children from the brutal disease spinal muscular atrophy.

Discover, share and read the best on the web

Follow RSS Feeds, Blogs, Podcasts, Twitter searches, Facebook pages, even Email Newsletters! Get unfiltered news feeds or filter them to your liking.

Get Inoreader
Inoreader - Follow RSS Feeds, Blogs, Podcasts, Twitter searches, Facebook pages, even Email Newsletters!